Giuseppe
Emeritus
[Source: Nature, full page: (LINK). Extract.]
Nature | Correspondence
Avian influenza: Ferret H7N9 flu model questioned
Marc Lipsitch<SUP>1, 2</SUP>
<SUP></SUP>
<SUP></SUP>
Journal name: Nature - Volume: 501, Page: 33 - Date published: (05 September 2013) - DOI: doi:10.1038/501033e - Published online 04 September 2013
________
We question the relevance to human pandemics of studies designed to investigate transmissibility of the avian influenza A(H7N9) virus between ferrets (M. Richard et al. Nature http://doi.org/njc; 2013; see also R. A. M. Fouchier et al. Nature 500, 150?151; 2013). Earlier studies have demonstrated ferret transmission of wild-type A(H7N9) virus (H.?
(?)
________
Affiliations: Harvard School of Public Health, Boston, Massachusetts, USA. On behalf of 4 co-authors (see Supplementary Information for full author list). Two authors declare competing financial interests.
Competing financial interests: M.L. has received consulting income and honoraria from AIR Worldwide, Novartis, Pfizer and Outcome Sciences, the latter on a project funded by Roche. D.F. has received grant support from Novartis.
Corresponding author: Correspondence to: Marc Lipsitch
-
-------
Nature | Correspondence
Avian influenza: Ferret H7N9 flu model questioned
Marc Lipsitch<SUP>1, 2</SUP>
<SUP></SUP>
<SUP></SUP>
Journal name: Nature - Volume: 501, Page: 33 - Date published: (05 September 2013) - DOI: doi:10.1038/501033e - Published online 04 September 2013
________
We question the relevance to human pandemics of studies designed to investigate transmissibility of the avian influenza A(H7N9) virus between ferrets (M. Richard et al. Nature http://doi.org/njc; 2013; see also R. A. M. Fouchier et al. Nature 500, 150?151; 2013). Earlier studies have demonstrated ferret transmission of wild-type A(H7N9) virus (H.?
(?)
________
Affiliations: Harvard School of Public Health, Boston, Massachusetts, USA. On behalf of 4 co-authors (see Supplementary Information for full author list). Two authors declare competing financial interests.
Competing financial interests: M.L. has received consulting income and honoraria from AIR Worldwide, Novartis, Pfizer and Outcome Sciences, the latter on a project funded by Roche. D.F. has received grant support from Novartis.
Corresponding author: Correspondence to: Marc Lipsitch
-
-------